Posted at 22 Jul, 14:15h in Press Release, Uncategorized by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Receives European Medicines Agency (EMA) Agreement on the Pediatric Investigation Plan (PIP) for AD04 in Alcohol Use Disorder
Posted at 06 Feb, 20:01h in Press Release, Uncategorized by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Commences Phase 3 Trial of AD04 for Alcohol Use Disorder